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Schizosaccharomyces pombe mitochondriaThe alternative oxidase (AOX) is a non-protonmotive ubiquinol oxidase that is found in all plants, some
fungi, green algae, bacteria and pathogenic protozoa. The lack of AOX in the mammalian host renders this
protein an important potential therapeutic target in the treatment of pathogenic protozoan infections.
Bioinformatic searches revealed that, within a putative ubiquinol-binding crevice in AOX, Gln242, Asn247,
Tyr253, Ser256, His261 and Arg262 were highly conserved. To conﬁrm that these amino-acid residues are
important for ubiquinol-binding and hence activity substitution mutations were generated and char-
acterised. Assessment of AOX activity in isolated Schizosaccharomyces pombe mitochondria revealed that
mutation of either Gln242, Ser256, His261 and Arg262 resulted in >90% inhibition of antimycin A-insensitive
respiration suggesting that hydroxyl, guanidino, imidazole groups, polar and charged residues in addition to
the size of the amino-acid chain are important for ubiquinone-binding. Substitution of Asn247 with
glutamine or Tyr253 with phenylalanine had little effect upon the respiratory rate indicating that these
residues are not critical for AOX activity. However replacement of Tyr253 by alanine resulted in a 72% loss of
activity suggesting that the benzoquinone group and not hydroxyl group is important for quinol binding.
These results provide important new insights into the ubiquinol-binding site of the alternative oxidase, the
identity of which maybe important for future rational drug design.omal alternative oxidase; Q(H2),
+44 1273 678433.
.
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In addition to its ubiquitous presence in all plants [1,2], the
cyanide-insensitive terminal alternative oxidase (AOX) is also found
in species of fungi, green algae, bacteria and protozoa and more
recently, in molluscs, nematodes and chordates but not in mammals
[3,4]. Of particular importance, however, is its presence in pathogenic
protozoa such as the blood parasite Trypanosoma brucei [5] the
intestinal parasites Cryptosporidium parvum [6,7] and Blastocystis
hominis and the emerging recognition that the AOX also plays a
critical role in the life cycle of yeasts such as Candida albicans [8].
Although the exact function of AOX within these organisms is
uncertain it is generally considered that the oxidase either plays a
key role in the reoxidation of cytosolic NADH (trypanosomes) [5] or in
the oxygen defence mechanism in the case of the anaerobic parasites
or yeasts [4]. It should be noted that to date there are no speciﬁc
inhibitors or treatments of trypanosomiasis or cryptosporidiosis and
current treatments of the former often have fatal side effects [5,7].
Because of their absence in the mammalian host, AOX proteins arenow considered to be important potential therapeutic targets in these
systems [9].
It is generally accepted that AOX is a non-haem di-iron carboxylate
protein in which the metal atoms are ligated by glutamate and
histidine residues within a 4-helix bundle [1,10,11]. The current
model of the AOX predicts a monotopic integral membrane protein
[1,10,11] associating with one leaﬂet of the lipid bilayer. Moreover
this model is supported by extensive site-directed mutagenesis
studies [11–17] and EPR spectroscopy has conﬁrmed the presence
of a binuclear iron centre [18,19]. More recently an FTIR study [20] of
the redox centres of a highly puriﬁed and stable preparation of
recombinant AOX (rTAO) from Trypanosoma brucei [21] conﬁrmed
the presence of a di-iron centre. This study revealed clear spectro-
scopic signatures of two distinct redox processes associated with the
full reduction of oxygen through to water. Spectroscopic signatures
contained features that could be assigned to the protonation of at least
one carboxylate group, further perturbations of carboxylic and
histidine residues, which to our knowledge, is the ﬁrst direct evidence
to conﬁrm that the alternative oxidase is indeed a di-iron carboxylate
protein [20].
In addition to an active site for the reduction of oxygen to water,
the AOX must contain a binding site for ubiquinol, the reducing
substrate of the protein. The structures of several quinone-binding
proteins have been determined to atomic resolution [22–24]
however, the general architecture of a quinone-binding site remains
1934 M.S. Albury et al. / Biochimica et Biophysica Acta 1797 (2010) 1933–1939elusive. Despite this, several characteristics thought to be important
for quinone-binding have been identiﬁed. Elucidation of the quinone-
binding site in the membrane associated cytochrome bc1 complex has
resulted in a model comparable to quinone-binding sites in
photosynthetic reaction centres in which the quinone-binding pocket
is formed by the ends of two transmembrane helices thus placing the
ubiquinone ring near the membrane interface [24,25]. Aromatic
residues identiﬁed close to quinone-binding regions may interact
with the quinone head group in a parallel stacking manner.
Additionally, Abramson et al. [24] observed a novel quinone-binding
domain containing a group of polar residues exposed to the interior of
the membrane that are uniquely conserved amongst ubiquinol
oxidases. A sequence analysis of respiratory and photosynthetic
complexes that react with quinones has resulted in the identiﬁcation
of a putative quinone-binding motif, consisting of an HR (His-Arg)
pair and a triad element [26]. In addition to residues highlighted by
Fisher and Rich [26], serine, arginine and tyrosine residues have been
identiﬁed by biochemical means as being critical for quinone-binding
in SQR (succinate:ubiquinone oxidoreductase) [27–29].
We [1] and others [10,11] proposed a model for the ubiquinol-
binding site in AOX based on accumulated data and bioinformatics
searches, which identiﬁed a hydrophobic pocket, betweenα-helices II
and III, which could act as a channel enabling the substrate to gain
access to the active site from the membrane-binding domain.
In this paper we investigate the validity of this model through a
series of site-directed mutagenesis experiments of residues identiﬁed
as being important for ubiquinol-binding through a bioinformatics
search. The study has revealed that Gln242, Ser256, His261 and
Arg262 are critical for ubiquinol-binding and Asn247 maybe impor-
tant for enzyme inhibition.
2. Materials and methods
2.1. Strains
The S. pombe strain used was Sp.011 (ade6–704, leu1–32, ura4-
D18, h−). The E. coli strains DH5α and JM110 were used for
ampliﬁcation of plasmids.
2.2. Site-directed mutagenesis and plasmid construction
Construction of pREP1-AOX and pREP1-Y253F, (used to express
wild-type AOX and the Y253F mutant in S. pombe) have been
described previously [13,30]. Mutagenesis of AOX was performed
using the Quick Change mutagenesis kit (Stratagene) according to
manufacturer's instructions, with plasmid pSLM-AOR [13]. Table 1
shows oligonucleotides used for each mutation, with altered codonsTable 1
Oligonucleotides used for site-directed mutagenesis to produce mutated forms of S.
guttatum AOX.
Mutation Primer sequence
Q242N 5′-CTGGTGCTGGCGGTGAACGGGGTCTTCTTCAAC-3′
5′-GTTGAAGAAGACCCCGTTCACCGCCAGCACCAG-3′
N247Q 5′-CAGGGGGTCTTCTTCCAGGCCTACTTCCTGG-3′
5′-CCAGGAAGTAGGCCTGGAAGAAGACCCCCTG-3′
Y253A 5′-CCTACTTCCTGGGGGCCCTGCTCTCCCCC-3′
5′-GGGGGAGAGCAGGGCCCCCAGGAAGTAGG-3′
S256T 5′-CTGGGGTACCTGCTCACCCCCAAGTTCGCCCAC-3′
5′-GTGGGCGAACTTGGGGGTGAGCAGGTACCCCAG-3′
H261A 5′-CCCCCAAGTTCGCCGCCCGGGTTGTGGGC -3′
5′-GCCCACAACCCGGGCGGCGAACTTGGGGG-3′
R262K 5′-CCAAGTTCGCCCACAAGGTTGTGGGCTACC-3′
5′-GGTAGCCCACAACCTTGTGGGCGAACTTGG-3′
Oligonucleotides used for site-directed mutagenesis with the altered codon in bold and
underlined. Note that the Y253Fmutated AOX has been described previously (see Ref 13).underlined. Each full length mutant AOX was excised on a BspHI–
BamHI fragment and ligated to the yeast expression vector pREP1/N
(a modiﬁed version of pREP1 [29,31] in which the NdeI site was
replaced with NcoI) which had been digested with NcoI and BamHI,
yielding pREP1-Q242N, pREP1-N247Q, pREP1-Y253A, pREP1-S256T,
pREP1-H261A and pREP1-R262K.
2.3. General molecular biology procedures
Oligonucleotides were obtained from MWG Biotech. Mutations
were originally identiﬁed by restriction analysis and conﬁrmed by
sequencing (Beckman Coulter Genomics). Full length clones were also
sequenced to conﬁrm the absence of nonspeciﬁc mutations. S. pombe
cells were transformed using a modiﬁed lithium acetate procedure
based on the method of Okazaki et al. [32]. Other procedures were as
described by Sambrook et al. [33].
2.4. Cell growth and mitochondrial isolation
Transformed S. pombe cells were batch-cultured in glucose
minimal medium [34] supplemented with 0.4 mM adenine and
0.7 mM uracil. Cells were grown in the absence of thiamine to
promote AOX expression under the control of the nmt promoter [31].
Mitochondria were isolated using the method outlined in [35] with
the modiﬁcations described in [36]. Mitochondrial protein concentra-
tions were determined using bicinchoninic acid with BSA as a
standard [37].
2.5. Oxygen uptake
Respiratory activity was measured with a Clark-type electrode
(Rank Brothers, Cambridge, U.K.) using 0.1 to 0.5 mg mitochondria
suspended in 0.4 mL air-saturated reaction medium (250 µM at 25 °C
[38]) containing 0.65 M mannitol, 20 mM MOPS/NaOH (pH 6.8),
1 mM MgCl2, 5 mM Na2HPO4 and 10 mM NaCl.
2.6. Western analysis
Separation of mitochondrial proteins on non-reducing SDS-
polyacrylamide gels, transfer to nitrocellulose membranes and
detection of AOX protein using monoclonal antibodies raised against
the S. guttatum AOX was performed as described previously [30].
3. Results
On the basis that the alternative oxidase is a monotopic protein
[10,11] which associates with one leaﬂet of the lipid bilayer in a
manner similar to that proposed for prostaglandin H2 synthase and
squalene synthase, two monotopic proteins for which the crystal
structure has been solved [39,40], we undertook a bioinformatic
approach to identify potential regions of AOX sequence which are
likely to associate with the membrane. Alignments of >100 AOX
sequences available to date have been compared with (1) other
members of the membrane-bound di-iron carboxylate proteins,
comprising the plastid terminal oxidases (PTOX) [41] and the CLK1
homologue, Coq7 [42] and (2) the soluble di-iron carboxylate
proteins, including Δ9desaturase, the R2 subunit of ribonucleotide
reductase (R2) and the hydroxylase component of methane mono-
oxygenase (MMOH). We searched for homology/insertions/deletions
in AOX sequences relative to these other proteins and took into
account hydropathy, proposed secondary structural elements and the
distribution of polar aromatic (Trp, Tyr) and basic residues (Lys, Arg)
which are prevalent at the interfacial regions of membrane proteins
(e.g. [43]). We also analysedmembrane-binding regions of monotopic
proteins assigned from crystal structures of prostaglandin H2
synthase, squalene synthase and fatty acid acyl hydrolase [39,40,44].
Table 2
Regions of AOX sequence identiﬁed by a bioinformatic approach as potential candidates
for membrane-binding regions.
Region Residues Sequence and key features
A 231–255 [RWYERALVLAVQGVFFNAYFLGYLL]. The most hydrophobic
region of the protein, ﬂanked by Trp/Tyr and Arg/Lys. May form
an aromatic-sided helix. More hydrophobic in AOX/PTOX/Coq7
than in soluble di-iron carboxylate proteins. Proposed to be the
major membrane-binding region of AOX.
B 180–190 [VAAVPGMVGGVLLH] The C-terminus of the ﬁrst helix in the
putative four-helix bundle. Hydrophobic face, a proline residue
may disrupt this helix. More hydrophobic in AOX/PTOX/Coq7
than in the soluble di-iron carboxylate proteins. Possibly
comprises a secondary membrane-binding region of AOX,
perhaps by indirect binding via intra-molecular association.
C 292–303 [PAPAIALDYWRL] Short region, this predicted helix is ﬂanked
by Trp/Tyr/Arg residues. Represents an insertion relative to the
soluble di-iron carboxylates and is absent in Coq7. Predicted to
be interfacial based on hydropathy analysis. Rich in Pro
residues. Not included in the current AOX model [16].
D 100–130 [VSYWAVPPSKEDGSEWRWTCFRPWETYQA] Region not
included in structural model [16]. Ill-deﬁned predicted
secondary structure, but rich in aromatic and Pro residues. Not
predicted to be hydrophobic, perhaps associates with interface
only. May form dimerising region.
Numbering and sequence information refer to S. guttatum AOX — see Fig. 1 for
locations. Regions have been ranked from A–D in order of anticipated importance.
Based on a hydropathy analysis, A and B, have previously been identiﬁed as potentially
interacting with the membrane [see refs. 10 and 11].
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be important for interactions of AOX with the inner mitochondrial
membrane were identiﬁed. These sequences are outlined in Table 2
and depicted in Fig. 1 and include the two regions of AOX that, due to
their hydropathy, have previously been proposed to interact with the
membrane [10,11]. Each region of sequence has been scrutinised and
ranked in terms of its potential for membrane binding, relative to theFig. 1. Diagrammatic representation of the proposed secondary structure arrangement
of the alternative oxidase. This ﬁgure represents membrane topology and location of
the hydrophobic crevice within the C-terminal portion of the AOX. Spheres represent
iron atoms. Note that the ﬁrst 164 residues of the mature protein along with residues
286–303 are not modeled as they do not have equivalents in Δ9-desaturase. A–D refer
to the hydrophobic regions identiﬁed in Table 2 whereas the amino-acids in red are
those proposed to be important for ubiquinol-binding.others, based on the criteria outlined above and on that basis themost
hydrophobic region of the protein is region A. Analysis of the
sequence reveals it is ﬂanked by Trp/Tyr and Arg/Lys residues and
may form an aromatic-sided helix. It appears to be more hydrophobic
in AOX/PTOX/Coq7 sequences than in soluble di-iron carboxylate
proteins and we would therefore propose it to be the major
membrane-binding region of AOX.
Based on modelling and bioinformatics searches, we and others
[1,10,11,45,46] have previously proposed that the sequence upstream
from region A (Table 2), which lies between α-helices II and III (see
Fig. 1), forms a hydrophobic pocket within the protein which acts as a
channel enabling its substrate, ubiquinol, to gain access to the active
site from the membrane-binding domain. Furthermore the structural
model shown in Fig. 1 is consistent with the known non-proto-
nmotive nature of ubiquinol oxidation in the alternative oxidase [47]
and the hydrophobic pocket is in close proximity to the membrane
surface and the active site of the protein. The 21 amino-acids within
this region contain residues likely to form H-bonds with carbonyl
groups of ubiquinone such as His and Ser in addition to those that
have the ability to stabilise ubiquinol-binding through π–π interac-
tions with benzoquinone ring such as Phe/Tyr/Arg, the majority of
which have been identiﬁed by biochemical means as being critical
for quinone-binding in SQR (succinate:ubiquinone oxidoreductase)
[27–29]. The region also contains residues identiﬁed through muta-
genesis studies as being important for inhibitor sensitivity in the
alternative oxidase [48].
Speciﬁcally the region (Fig. 1) contains an HR pair (His261/
Arg262), previously identiﬁed by Fisher and Rich [26] as part of a
potential hydroquinone-binding motif, and two of the three residues
identiﬁed by inhibitor-resistant screening as being important in
ubiquinol-binding [48], ﬂank the HR pair. Tyr253, a highly conserved
residue that we have previously postulated to be important in
ubiquinol-binding [1,45], is positioned in the hydrophobic pocket
proximal to the HR pair. Importantly this region also contains Gln242
and Asn247, the only signiﬁcantly polar residues in this hydrophobic
region, whichwe have previously shown to be different to that seen in
the trypanosomal AOX isozymes [1,46], variation of which appears to
result in differences in sensitivity to the inhibitor ascofuranone [16].
The putative quinone-binding domain also contains polar and charged
residues similar to those of the ubiquinol oxidase of E. coli [24] and
also a highly conserved serine residue (Ser256) which appears to play
a key role in quinone-binding of complex II [27,28].
Fig. 2 shows a multiple sequence alignment of the putative
ubiquinol-binding site from a variety of species including both
thermogenic and non-thermogenic plants, metazoa, eukaryotes,
proteobacteria and parasites. What is very striking from this multiple
alignment is the extent to which Gln242, Tyr253, His261 and Arg262
are fully conserved across all species. Other residues that show
signiﬁcant conservation include, Ser256, Pro257 and Arg/Lys258.
Given the high degree of conservation, residues Gln242, Tyr253,
His261 and Arg262 in addition to Asp247 and Ser256 were chosen for
mutagenesis. In this study, rather than mutating all of these residues
to alanine more subtle changes were introduced in order to probe the
relative importance of the hydroxyl groups (in the case of Tyr253 and
Ser256), the guanidino group (Arg262) and, in order to maintain the
polar nature, conservative changes in the case of Gln242 and Asp247.
His261, however, was mutated to alanine since the methyl group of
this residue is not capable of forming hydrogen bonds with the
carbonyl group of ubiquinone.
Table 3 summarises the results obtained when this series of site-
directed mutations of the Sauromatum guttatum alternative oxidase
were expressed in S. pombe. The extent towhich themutation affected
alternative oxidase activity in isolated S. pombe mitochondria was
assessed by measuring the rate of oxygen uptake in the presence of
antimycin A and ascertaining the sensitivity to the alternative oxidase
inhibitor, octylgallate. Since respiratory activity is not necessarily
Fig. 2. Alignment of the proposed Q binding region of AOX sequences from a number of different species, grouped by phyla. Conserved residues are shown in colour— R/K in red, H in
blue, Q/N in green, Y in teal and P in yellow. Note, Q binding region is deﬁned as residues 236–264 as per Sauromatum guttatum numbering (P22185). Alignment created using
ClustalW and viewed using SeaView. Full species names and accession (UniProt) numbers — Arum concinnatum B9X258; Nelumbo nucifera C0SUJ4; Philodendron bipinnatiﬁdum
Q65YQ8; Sauromatum guttatum P22185; Symplocarpus renifolius Q5KSN9; Dracunculus vulgaris Q65YS0; Arabidopsis thaliana O23913; Daucus carota B1P5D1; Glycine max O82518;
Oryza sativa subsp. japonica Q8W855; Saccharum ofﬁcinarum Q66PX0; Triticum aestivum Q8S913; Zea mays Q8GT27; Aspergillus niger O74180; Candida albicans O93853; Coprinopsis
cinerea A8NDS4; Chaetomium globosum Q2GZL4; Coccidioides immitis Q1E8R2; Cryptococcus neoformans var. grubii Q8NKE2; Gelasinospora sp. (strain S23) Q8J1Z2; Neurospora
crassa Q01355; Penicillium chrysogenum Q6TBA7; Uncinocarpus reesii C4JFI2; Trichoplax adhaerens B3RQ52; Anadara ovalis C5HYP9; Nematostella vectensis A7RXL2; Acanthamoeba
castellanii Q07CY9; Aliivibrio salmonicida (strain LFI1238) B6EGE6; Erythrobacter sp. NAP1 A3WI95; Methylophaga thiooxidans C0N2S5; Novosphingobium aromaticivorans (strain
DSM 12444) Q2G807; Octadecabacter antarcticus 238 B5K463; Photobacterium profundum 3TCK Q1YY39; Phenylobacterium zucineum (strain HLK1) B4R9G7; Roseobacter
denitriﬁcans Q164N3; Roseovarius sp. TM1035 A6DV40; Sphingomonas wittichii (strain RW1/DSM 6014/JCM 10273) A5VGI7; Thiobacillus denitriﬁcans Q3SHK3; Thioalkalivibrio sp.
K90mix B9ZS20; Vibrio campbellii AND4 A8TAF3; Vibrio harveyi A7MXL7; Vibrio shilonii AK1 A6D0V8; Blastocystis hominis (not in database yet); Cryptosporidium hominis Q5CGN5;
Cryptosporidium parvum Q761U6; Trypanosoma brucei brucei Q26710; Perkinsus marinus C5K4Z3.
Table 3
Effect of site-directed mutagenesis on alternative oxidase activity in S. pombe
mitochondria.
Oxidase Activity nmolO2/min/mg % Control
Wt 54±8 100
Q242N 3±1 6
N247Q 52±6 96
Y253F 33±6 61
Y253A 15±3 28
S256T 4±2 7
H261A 3±1 5
R262K 3±1 6
Antimycin A-insensitive oxygen-uptake rates in S. pombe mitochondria containing
either wild-type or mutated AOX proteins. Rates (±standard error) were measured in
the presence of 2 µM antimycin A, 2 mMNADH, 9 mM succinate, 0.2 mMATP and 9 mM
glutamate. Percentages refer to the respective rates relative to AOXwt.
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dehydrogenases [49], we used a cocktail of substrates (NADH,
succinate, and glutamate in the presence of ATP) as we have shown
previously that in the presence of these substrates Q-reducing capacity
is maximal and AOX exerts more than 95% of total ﬂux control over
antimycin A-resistant NADH oxidation in isolated S. pombemitochon-
dria [49]. It should be noted that, in the absence of antimycin A,
respiratory control ratios greater than 2, following addition of FCCP,
were observed with all of the mutants indicating that the mutations
speciﬁcally affected the alternative pathway and not the main
cytochrome pathway or mitochondrial integrity. What is immediately
obvious from Table 3 is that Gln242, Ser256, His261 and Arg262 are
structurally critical for alternative oxidase activity since even
conservative substitution results in greater than 93% inhibition of
Fig. 3. Western blot analysis of mutated AOX proteins expressed in S. pombe
mitochondria. Western blots of mitochondria puriﬁed from S. pombe expressing wild-
type or mutant AOX probed with AOA antibodies. Mitochondrial proteins (15 µg per
lane), loaded on two separate gels (A and B), are as follows: lane1, wild-type AOX; lane
2, Q242N; lane 3, N247Q; lane 4, wild-type AOX; lane 5, Y253F; lane 6, Y253A; lane 7,
S256T; lane 8, H261A; lane 9, R262K. Numbers on the right of the immunoblot refer to
molecular masses of the standards (in kDa).
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species possessing the alternative oxidase (Fig. 2), replacement with
asparagine results in an inactive protein even though the polar nature
of the substitution is maintained. Unlike the Q242N mutation,
replacement of N247 with glutamine, however, resulted in an active
protein. Such a result was not surprising since this residue appears
only to be fully conserved in plants and fungi and not in parasites or in
some members of the proteobacteria (see Fig. 2). When Ser256, a
residue highly conserved across a substantial number of organisms
and equivalent to an essential serine implicated in quinone-binding
and reduction in Complex II [27,28], was replaced with threonine the
mutated alternative oxidase protein was inactive. Such a result
suggests that although the hydroxyl group is not critical for activity
the steric environment probably is. Arg262,which is part of theHRpair
[26], is almost completely conserved throughout all AOX sequences
(see Fig. 2) and the question arises as to why lysine is not found at this
position. Replacement of Arg262 with lysine, a subtle mutation which
retains the positive charge, results in an inactive protein, suggesting
that the guanidino group rather than its positive charge is critical for
antimycin-resistant activity. We are aware, however, that in terms of
space occupation, the guanidino group extends amuch longer distance
than the primary amine of lysine and furthermore there are more
hydrogen atoms available for hydrogen bonding with arginine in
comparison to lysine. Replacement ofHis261with alaninehas a similar
effect on activity to that observed with R262K, namely total inhibition
of antimycin-resistant respiratory activity. As indicated above and as
can be seen from Fig. 2, His261 is conserved across all AOX sequences
isolated to date and the lack of activity observed following its
substitution suggests that the imidazole group plays some critical
role in the maintenance of optimal structure/reactivity possibly
through participating in hydrogen-bonding.
With respect to Tyr253, a highly conserved residue, interestingly
mutation to phenylalanine resulted in an active protein thereby
suggesting that it is the aromatic ring and not H-bonding through the
hydroxyl group that is important for ubiquinol-binding. This notion is
further conﬁrmed by the ﬁnding that replacement of Tyr253 with
alanine, does indeed result in loss of activity (72% inhibition). In some
senses the fact that the protein was still partially active was an
unexpected result since we had assumed that such a substitution
would have resulted in total inhibition due to loss of the aromatic ring
thereby preventing the binding of the quinone head group. Similar
inhibitory effects have, however, been observed by Nakamura et al.
[16] who found that the same mutation in T. vivax recombinant AOX
only resulted in a 44% inhibition of the AOX activity.
In order to ascertain that the loss in alternative oxidase activity
observed with Gln242, Ser256, His261 and Arg262mutations is not due
to themutated protein failing to associate with the inner mitochondrial
membrane western blot analysis, using plant AOA (alternative oxidase-
all) antibodies, was performed. Analysis of Fig. 3 reveals three areas of
interest, namely a band at 32 kDa, which represents AOX monomer, a
band at approx 42 kDa, and bands at 76 kDa which represent the
dimeric form of AOX. It should be noted that Fig. 3A and B represent 2
separate preparations which probably accounts for the variation in
monomer intensity between the various mutants. The band at 42 kDa,
which we have previously identiﬁed as AOX precursor protein [30],
does, however, vary considerably amongst the mutants, the reasons for
which are currently unclear. Nevertheless, despite any slight difference
in signal intensity of themonomer amongst the variousmutants, which
may be due to experimental variation, it is readily apparent from Fig. 3
that all of the mutated AOX proteins are expressed in signiﬁcant
amounts and to a similar order of magnitude as wild-type AOX in S.
pombemitochondria. We can therefore conclude that any difference in
activity amongst the various mutants cannot be attributed to a lack of
the mutated forms of AOX failing to associate with S. pombe
mitochondrial membranes but is more a reﬂection of the importance
of that residue for ubiquinol-binding.4. Discussion
A key challenge in understanding the structure–function relation-
ship of the alternative oxidases rests upon the identiﬁcation of the
ubiquinone-binding site. A detailed knowledge of the nature of this
binding site is important not only with respect that it may reveal
whether or not there is a common architecture that can be applied to
quinone-binding sites in general and hence provide an insight into the
mechanism of binding but perhaps more importantly could assist in
the suitable rational development of phytopathogenic fungicides and
anti-parasitic drugs that are speciﬁcally targeted to the alternative
oxidase. As indicated earlier it is now generally recognized that the
distribution of the alternative oxidase is substantially wider than
previously thought and is no longer restricted to plants, some fungi
and protists but is also widespread amongst human parasites such as
trypanosomes, Cryptosporidium parvum, and Blastocystis hominis (see
Fig. 2).
We, and others [1,10,11,45,46], have previously suggested that the
region between helices II and III is themost likely site to be involved in
the binding of ubiquinol. This is based upon the following observa-
tions namely (1) when any of the alternative oxidase sequences are
mapped onto the structure of the Δ9-desaturase protein a hydropho-
bic crevice is revealed which reaches down to the active site of the
protein [10] (2) the crevice contains residues, identiﬁed by Berthold
[48] in a mutagenesis screen, that result in an increased resistance to
the presumed competitive inhibitor SHAM [50]; (3) these residues
ﬂank the extremely well conserved HR dyad, part of a potential
hydroquinone-binding motif [26] and (4) the hydrophobic pocket
also contains a highly conserved tyrosine [45] which is positioned
proximal to the HR pair.
In this study we have identiﬁed a number of key residues within
this hydrophobic crevice that appear to be critical for alternative
oxidase activity which include Tyr253, Ser256, His261 and Arg262.
Mutation of these residues reveals that the presence of hydroxyl,
guanadino, imidazole and aromatic groups, polar and charged
residues in addition to the size of the amino-acid chain are important
for ubiquinone-binding.
In addition to these amino-acids, analysis of the differences in
sensitivity of the trypanosomal isozymes (Trypanosoma brucei (Tb)
and vivax (Tv)) [16] to the TAO inhibitor, ascofuranone [51], led
Crichton [46] to identify two further residues (Gln242 and Asn247)
which are the only signiﬁcantly polar residues that are conserved in
this hydrophobic region [see ref. 1 for a review]. Gln242 is fully
Fig. 4. Alignment of the proposed Q binding region of AOX of several fungal plant pathogens compared with Sauromatum guttatum AOX. Alignment constructed using ClustalW, and
viewed using SeaView. As before, the Q binding region is deﬁned as residues 236–264 as per Sauromatum guttatum numbering (P22185). Conserved residues are shown in colour—
R/K in red, H in blue, Q/N in green, Y in teal and P in yellow. Full species names and accession (UniProt) numbers — Sauromatum guttatum P22185; Magnaporte grisea O93788;
Neurospora crassa Q01355; Botrytis cinerea Q8NJ59; Candida albicans AOX1 O93853; Candida albicans AOX2 Q9UV71; Podospora anserina Q9C206; Metarhizium anisopliae
Q45N56; Aspergilus niger O74180; Pichia stipidis Q9P414.
1938 M.S. Albury et al. / Biochimica et Biophysica Acta 1797 (2010) 1933–1939conserved (see Fig. 2) across all organisms (except for PTOX) and
mutation to Asn results in complete loss of activity. Replacement of
Asn247with Gln, however, has relatively little effect upon activity and
Fig. 2 indicates that Asn247 has been replaced by either leucine (Tb)
or serine (Tv). Interestingly Tv-AOX exhibits an ~8-fold lower KM for
ubiquinol-1 than Tb-AOX [16] This difference in afﬁnity for Q
correlates with a higher sensitivity of the Tv-AOX to ascofuranone,
and explains the higher potency of this drug against T. vivax parasites
speciﬁcally [16]. It is interesting to speculate that since the residue at
position 247 is the only difference between the plant and trypano-
some sequence it may play a key role in ascofuranone sensitivity and
therefore represents an attractive residue for future mutagenesis
studies. In particular, introducing a serine or leucine at position 247 in
the S. guttatum AOX (to reﬂect the situation found in the trypanosome
isozymes) may allow the involvement of this residue in Q binding/
inhibition to be better assessed and such information may prove
useful in the future rational design of anti-parasitic drugs [5,9,51].
As indicated earlier, the alternative oxidase is also widespread
amongst fungi and similar to plants is induced when the organism is
stressed [3,4]. In recent years agricultural fungal control has resulted
in the development fungicides speciﬁcally targeted to the quinol-
oxidation site (Qo) of the cytochrome bc1 complex [52]. One
important group of Qo site inhibitors that have proved effective in
the control of plant pathogens are the strobilurin fungicides, the most
widely used one being azoxystrobin [53]. Unfortunately resistance to
this fungicide often develops resulting in an inability to control fungal
pathogens through continued application [54,55]. Although the
mechanism for conferring resistance to Qo fungicides is still
controversial [55–57] there is good evidence to suggest that the
addition of inhibitors, such as azoxystrobin, to fungal pathogens
results in a strong induction of the alternative oxidase [55]. Whether
the development of AOX can account for ﬁeld resistance to
strobilurins is debatable [55–57] nevertheless it is interesting to
ascertain whether there is any degree of similarity within the
proposed Q-binding site of the alternative oxidase. In general there
is a relatively low level of amino-acid identity between plant and
fungal AOX sequences, however, Fig. 4 indicates that within the
putative ubiquinone-binding site identiﬁed in this study, there is a
high degree of conservation of the key residues namely Gln242.
Asn247, Tyr253, His261 and Arg262, in both plant and fungal AOXs.
If these residues do indeed prove critical for Q binding then the
designof inhibitors basedon this sequencemayproveuseful in the long-
term control of fungicide resistance. Although SHAM has previously
been shown to be ineffective at controlling fungicide resistance when
used alongside strobilurin fungicides [57], it should be recognized that
SHAM is not speciﬁc for the alternative oxidase [50] and furthermore, in
comparison to ascofuranone, is a poor inhibitor since it has to be used at
very high concentrations (µM) even with a puriﬁed protein [51]. The
fact that the Ki for ascofuranone inhibition of the cytochrome bc1
complex is µMwhereas for AOX it is sub-nM [16,51] does in our opinionclearly suggest that the two quinol-binding sites are different. Therefore
until more potent and speciﬁc inhibitors of the AOX, such as
ascofuranone, are developed it is difﬁcult to give a deﬁnitive answer
as to whether or not the fungal alternative oxidase does play any
signiﬁcant role in ﬁeld strobilurin resistance. Nevertheless the fact that
fungal pathogens do express an alternative oxidase when treated with
fungicides is, in our opinion, sufﬁcient evidence to warrant further
investigation possibly by developing fungicides that can act on the
ubiquinone-binding site identiﬁed in this paper and that could be used
alongside strobilurin fungicides.
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